NissensonA.R.Measuring, managing, and improving quality in the end-stage renal disease treatment setting: Peritoneal dialysis.Am J Kidney Dis1994; 24: 368–75.
2.
TaylorG.J., BagbyR.M., ParkerJ.D.A.Disorders of Affect Regulation: Alexithymia in Medical and Psychiatric Illness.Cambridge, UK: Cambridge University Press; 1997.
3.
FukunishiI., MaedaK., KubotaM., TominoY.Association of alexithymia with low utilization and perception on a measure of social support in patients on peritoneal dialysis.Psychol Rep1997; 80: 127–30.
4.
HaysR.D., KallichJ.D., MapesD.L., CoonsS.J., CarterW.B.Development of the Kidney Disease Quality of Life (KDQOL) instrument.Qual Life Res1994; 3: 329–38.
5.
LoasG., CorcosM., StephanP., PelletJ., BizouardP., VenisseJ.L.Factorial structure of the 20-item Toronto Alexithymia Scale: Confirmatory factorial analyses in non clinical and clinical samples.J Psychosom Res2001; 50: 255–61.
6.
LeplegeA., EcosseE., CosteJ., PouchotJ., PernegerT.Le questionnaire MOS SF-36: manuel de l'utilisateur et guide d'interpretation des scores.Paris: Editions ESTEM; 2001.
7.
CarmichaelP., PopoolaJ., JohnI., StevensP.E., CarmichaelA.R.Assessment of quality of life in a single centre dialysis population using the KDQOL-SF questionnaire.Qual Life Res2000; 9: 195–205.
8.
FukunishiI., NumataY., HattoriM.Alexithymia and defense mechanisms in myocardial infarction.Psychol Rep1994; 75: 219–23.